341 related articles for article (PubMed ID: 36134136)
1. A review on contemporary nanomaterial-based therapeutics for the treatment of diabetic foot ulcers (DFUs) with special reference to the Indian scenario.
Sethuram L; Thomas J; Mukherjee A; Chandrasekaran N
Nanoscale Adv; 2022 May; 4(11):2367-2398. PubMed ID: 36134136
[TBL] [Abstract][Full Text] [Related]
2. Application of 3D Bioprinting Technologies to the Management and Treatment of Diabetic Foot Ulcers.
Tan CT; Liang K; Ngo ZH; Dube CT; Lim CY
Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33096771
[TBL] [Abstract][Full Text] [Related]
3. Proteomics and transcriptomics explore the effect of mixture of herbal extract on diabetic wound healing process.
Liu Y; Zhang X; Yang L; Zhou S; Li Y; Shen Y; Lu S; Zhou J; Liu Y
Phytomedicine; 2023 Jul; 116():154892. PubMed ID: 37267693
[TBL] [Abstract][Full Text] [Related]
4. Harnessing Bioprinting Technologies for Diabetic Wound Regeneration.
Dhankhar S; Garg N; Chauhan S; Saini M; Singh TG
Curr Pharm Biotechnol; 2024 Jun; ():. PubMed ID: 38910470
[TBL] [Abstract][Full Text] [Related]
5. Strategy for Treatment of Infected Diabetic Foot Ulcers.
Chang M; Nguyen TT
Acc Chem Res; 2021 Mar; 54(5):1080-1093. PubMed ID: 33596041
[TBL] [Abstract][Full Text] [Related]
6. The role of gel wound dressings loaded with stem cells in the treatment of diabetic foot ulcers.
Chen X; Wu J; Cao X; Jiang H; Wu Z; Zeng Z; Chen H; Zhang J
Am J Transl Res; 2021; 13(12):13261-13272. PubMed ID: 35035674
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Polymer-based Wound Dressings for the Treatment of Diabetic Foot Ulcer: An Overview of State-of-the-art.
Hussain Z; Thu HE; Shuid AN; Katas H; Hussain F
Curr Drug Targets; 2018; 19(5):527-550. PubMed ID: 28676002
[TBL] [Abstract][Full Text] [Related]
8. Diabetic Foot Ulcers: A Review of Debridement Techniques.
Sa BC; Maskan Bermudez N; Shimon SV; Kirsner RS
Surg Technol Int; 2024 Feb; 44():. PubMed ID: 38372560
[TBL] [Abstract][Full Text] [Related]
9. Leveraging Potential of Nanotherapeutics in Management of Diabetic Foot Ulcer.
Pandey S; Shaif M; Ansari TM; Shamim A; Kushwaha P
Exp Clin Endocrinol Diabetes; 2022 Oct; 130(10):678-686. PubMed ID: 35240693
[TBL] [Abstract][Full Text] [Related]
10. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptides, Inflammation, Biofilms, and diabetic Foot Ulcers.
Yang S; Hu L; Han R; Yang Y
Exp Clin Endocrinol Diabetes; 2022 Jul; 130(7):439-446. PubMed ID: 34225369
[TBL] [Abstract][Full Text] [Related]
12. Physiological and Pathophysiological Aspects of Diabetic Foot Ulcer and its Treatment Strategies.
Ramachandran V; Mohanasundaram T; Karunakaran D; Gunasekaran M; Tiwari R
Curr Diabetes Rev; 2023; 19(8):e031122210617. PubMed ID: 36330634
[TBL] [Abstract][Full Text] [Related]
13. Topical gel-based biomaterials for the treatment of diabetic foot ulcers.
Bardill JR; Laughter MR; Stager M; Liechty KW; Krebs MD; Zgheib C
Acta Biomater; 2022 Jan; 138():73-91. PubMed ID: 34728428
[TBL] [Abstract][Full Text] [Related]
14. Dual-functional hybrid quaternized chitosan/Mg/alginate dressing with antibacterial and angiogenic potential for diabetic wound healing.
Wang M; Yang Y; Yuan K; Yang S; Tang T
J Orthop Translat; 2021 Sep; 30():6-15. PubMed ID: 34466384
[TBL] [Abstract][Full Text] [Related]
15. Nanotherapeutic approach to treat diabetic foot ulcers using tissue-engineered nanofiber skin substitutes: A review.
Bahmad HF; Poppiti R; Alexis J
Diabetes Metab Syndr; 2021; 15(2):487-491. PubMed ID: 33668000
[TBL] [Abstract][Full Text] [Related]
16. Innovative Functional Biomaterials as Therapeutic Wound Dressings for Chronic Diabetic Foot Ulcers.
Da Silva J; Leal EC; Carvalho E; Silva EA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373045
[TBL] [Abstract][Full Text] [Related]
17. Toward Developing Immunocompetent Diabetic Foot Ulcer-on-a-Chip Models for Drug Testing.
Ejiugwo M; Rochev Y; Gethin G; O'Connor G
Tissue Eng Part C Methods; 2021 Feb; 27(2):77-88. PubMed ID: 33406980
[TBL] [Abstract][Full Text] [Related]
18. Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets.
Fu K; Zheng X; Chen Y; Wu L; Yang Z; Chen X; Song W
Front Pharmacol; 2022; 13():1050630. PubMed ID: 36339630
[TBL] [Abstract][Full Text] [Related]
19. Single-cell profiling reveals transcriptomic signatures of vascular endothelial cells in non-healing diabetic foot ulcers.
Lu Y; Liu X; Zhao J; Bie F; Liu Y; Xie J; Wang P; Zhu J; Xiong Y; Qin S; Yang F; Chen L; Xu Y
Front Endocrinol (Lausanne); 2023; 14():1275612. PubMed ID: 38107519
[TBL] [Abstract][Full Text] [Related]
20. Negative pressure wound therapy, artificial skin and autogenous skin implantation in diabetic foot ulcers.
Chia-Jui H; Yu L; Jiang YQ; Tan W; Gao GM; Li HB; Han L
J Wound Care; 2022 Jan; 31(1):40-46. PubMed ID: 35077212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
